Wednesday, November 30, 2016 8:25:37 PM
Excerpts:
"The House of Representatives passed the 21st Century Cures Act by a 392 to 26 vote, showing a bipartisan spirit that has been rare in recent years. The Cures Act now heads to the Senate, for a vote early next week."
"The Cures Act includes numerous provisions that set the stage for the faster approval of prescription drugs and medical devices. Although proponents claim these new measures will not lower safety standards, numerous critics, including some former Food and Drug Administration officials and national consumer groups, disagree. They have argued that FDA already moves faster than similar agencies in other countries."
"But party leaders on both sides of the aisle said they expect the bill to pass the Senate."
www.statnews.com/2016/11/30/21st-century-cures-act-house/
AdvaMed Commends Revised 21st Century Cures Package
Excerpts:
“Patients are looking to medical technology companies to develop the next generation of life-saving, life-enhancing devices and diagnostics. These advancements are key to solving the nation’s health care challenges, as greater patient access to innovative technologies generates efficiencies and cost savings for the health care system while improving the quality of care."
“The package includes a number of important improvements to FDA’s medical device premarket program designed to increase the efficiency, predictability and transparency of the agency’s review process. The most significant of these builds on initiatives already underway within FDA to help create an expedited pathway for breakthrough medical technologies – "
www.advamed.org/newsroom/press-releases/advamed-commends-revised-21st-century-cures-package
This is bigger than most people realize IMO. The US Senate will Tee It Up for a vote next week.
Breathtec Biomedical Inc - Go Long
/////AMG
P.S. There is already an FDA expedited/fast path to market for medical devices (2 years). New legislation narrows a path down to No Clinical Trial Necessary depending on type of device and strength of "Real World" documentation. This could get very interesting folks...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM